@inproceedings{inproceedings, title  = {{The importance of adjusting for treatment crossover bias in oncology clinical trials: An analysis of the EGF104900 trial in metastatic breast cancer (mBC)}},

 url = {{}},

 year = {{2013}},

 month = {{5}},

 author = {{Paracha N and Davies A and Latimer N and Parker C and Mealing S and Scott D and Padhiar A and Schulpher M and Wang Q}},

 volume = {{31}},

 journal = {{JOURNAL OF CLINICAL ONCOLOGY}},

 issue = {{15}},

 note = {{Accessed on 2025/02/14}}}